Trial Profile
Flecainide for the treatment of chronic neuropathic pain: a phase II trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Flecainide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 29 May 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
- 25 Oct 2005 New trial record.